NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which is NOT listed as a warning for Mirabegron (Myrbetriq)?

Urinary retention
Increased blood pressure
Angioedema
Hair loss

The correct answer is: Hair loss

Mirabegron (Myrbetriq) is a medication used to treat overactive bladder. It works by relaxing the bladder muscles, allowing for better control and less frequent urges to urinate. However, like all medications, it carries potential side effects and warnings. In this case, the three listed warnings for Mirabegron are urinary retention, increased blood pressure, and angioedema. This means that people taking Mirabegron should monitor for these potential side effects and seek medical attention if they occur. Hair loss, however, has not been reported as a potential side effect of this medication and is therefore NOT listed as a warning. This does not mean that hair loss cannot occur while taking Mirabegron, but it is not a known side effect of the medication. As always, if you experience any concerning side effects while taking Mirabegron, it is important to speak with your healthcare provider.